EarningsQ4 2021 Earnings Report

AbbVie (ABBV) Q4 2021 Earnings Report

0 Followers

MX:ABBV Q4 2021 EPS Results

Actual EPS$59.82

Consensus EPS$59.33

Beat/MissBeat by +$0.49

One Year Ago EPS$52.77

Actual Revenue$269.04B

Expected Revenue$270.22B

Beat/MissMissed by -$1.18B

YoY Revenue Growth+7.42%

QuarterQ4 2021

Date02/02/2022

TimeBefore Open

Conference CallWednesday, February 2, 2022

MX:ABBV Upcoming Earnings

AbbVie's next earnings date is estimated for October 30, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 30, 2026	2026 (Q3)	69.75 / -	33.616	―
Jul 31, 2026	2026 (Q2)	65.15 / 65.97	53.678	22.90% (+12.29)
Apr 29, 2026	2026 (Q1)	46.85 / 47.89	44.461	7.72% (+3.43)
Feb 04, 2026	2025 (Q4)	47.95 / 48.98	39.038	25.46% (+9.94)
Oct 31, 2025	2025 (Q3)	31.92 / 33.62	54.22	-38.00% (-20.60)
Jul 31, 2025	2025 (Q2)	52.05 / 53.68	47.894	12.08% (+5.78)
Apr 25, 2025	2025 (Q1)	43.00 / 44.46	41.75	6.49% (+2.71)
Jan 31, 2025	2024 (Q4)	38.23 / 39.04	50.425	-22.58% (-11.39)
Oct 30, 2024	2024 (Q3)	52.77 / 54.22	53.316	1.69% (+0.90)
Jul 25, 2024	2024 (Q2)	46.38 / 47.89	52.594	-8.93% (-4.70)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed